Systemic Exposure Changes
Systemic Exposure Changes is a pharmacokinetic phenomenon characterized by alterations in the concentration-time profile of a drug in the systemic circulation resulting from the concomitant administration of another drug, thereby affecting its absorption, distribution, metabolism, or excretion.
94
Publications
3.6K
Citations
645
Authors
246
Institutions
Publications per year
2017–2026
25
Parents
94
Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea
Samuel Frank, David Stamler, Elise Kayson et al. · JAMA Neurology · 2017 · 212 citations
Improved regional selectivity of hepatic arterial bcnu with degradable microspheres
Shaker R. Dakhil, William D. Ensminger, Kyung Cho et al. · Cancer · 1982 · 144 citations
Pharmacy, Oncology, Pharmacology +15
1–5 of 94
645
The University of Texas MD Anderson Cancer Center, United States
3 publications · 53 citations
3
h-index
3
h-index
2
h-index
2
h-index
2
h-index
1–5 of 645
246

St. Jude Children's Research Hospital
Memphis, United States
3 h-index
11 publications
223 citations

University of Oslo
Oslo, Norway
3 h-index
12 publications
649 citations
The University of Texas MD Anderson Cancer Center
Houston, United States
3 h-index
18 publications
375 citations
Bristol-Myers Squibb (United States)
New York, United States
2 h-index
7 publications
167 citations
Jilin University
Changchun, China
2 h-index
18 publications
329 citations

University of Genoa
Genoa, Italy
2 h-index
10 publications
1.2K citations
Chinese University of Hong Kong
Hong Kong, Hong Kong
2 h-index
12 publications
642 citations
Marymount University
Arlington, United States
2 h-index
5 publications
574 citations
1–8 of 246
Repository · 6 publications · 156 citations
6
h-index
BJCP · 5 publications · 133 citations
5
h-index
4 publications · 113 citations
4
h-index
CPT · 3 publications · 139 citations
3
h-index
3 publications · 116 citations
3
h-index
1–5